Why Covid-19 Testing Stocks Are Selling Off Despite Surging Demand
- Wednesday, January 19, 2022, 7:16
- Market
- Add a comment
Our indicative theme on Covid-19 Testing Stocks – which includes companies that produce or carry out tests for Covid-19 infections – has underperformed considerably thus far in 2022, declining by about 13% year-to-date, compared to the S&P 500 which has declined about 2% over the same period…
About the Author
admin123 has written 23446 stories on this site.
